SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-031808
Filing Date
2021-03-04
Accepted
2021-03-04 06:20:28
Documents
1
Group Members
DR. JAMES I. HEALYDR. MAHA KATABIDR. MICHAEL F. POWELLSOFINNOVA MANAGEMENT X, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm218625d1_sc13d.htm SC 13D 106752
  Complete submission text file 0001104659-21-031808.txt   108484
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners X, L.P. (Filed by) CIK: 0001680200 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Subject) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91586 | Film No.: 21712494
SIC: 2834 Pharmaceutical Preparations